We are leveraging a proprietary #smallmolecule as a potential breakthrough solution for #chroniccough.
Exxel Pharma
Pharmaceutical Manufacturing
Aurora, Colorado 139 followers
Advancing Breakthrough Therapeutics to Transform the Treatment of Neuronal Hypersensitivity Disorders.
About us
Exxel Pharma is a privately held company focused on developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. The Company’s lead program, EX937, is a first-in-class, proprietary small molecule being developed for refractory chronic cough, a large underserved market with no current FDA-approved therapies, that affects approximately 10% of the global population. Leveraging a differentiated approach by inhibiting the FAAH enzyme, EX937 has demonstrated efficacy and favorable safety in its ability to modulate chronic cough in preclinical models. The Company is rapidly advancing the development of EX937 towards a first-in-human Phase 1/1b study. EX937 also has the potential to be utilized across a number of blockbuster indications, including hyperactive bladder, peripheral neuropathic pain and migraine headaches.
- Website
-
http://www.exxelpharma.com
External link for Exxel Pharma
- Industry
- Pharmaceutical Manufacturing
- Company size
- 2-10 employees
- Headquarters
- Aurora, Colorado
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Neuronal Hypersensitivity Disorder, Chronic Cough, Hyperactive Bladder, Neuropathic Pain, and Migraines
Locations
-
Primary
Get directions
12635 E Montview Blvd
Suite 100
Aurora, Colorado 80045, US
Employees at Exxel Pharma
Updates
-
Our lead program has the potential to be applied across a number of high value indications for patients in need. Learn more here: https://bit.ly/49cZ3MO #chroniccough #neuropathicpain #migraine #hyperactivebladder
-
-
#HappeningToday at 12 PM ET! Our President and CEO, Soren Mogelsvang, PhD will be presenting at the Virtual Investor #LunchBreak event! Access the event here: https://bit.ly/3xZUTtr #VirtualInvestor #chroniccough #neuropathicpain #migraine #hyperactivebladder
-
-
We are focused on developing novel therapeutics for the treatment of neuronal hypersensitivity disorders. https://bit.ly/3ZQ0Qmu #chroniccough #neuropathicpain #migraine #hyperactivebladder
-
-
#SaveTheDate for our participation in the Virtual Investor #LunchBreak event! We look forward to seeing you there! https://bit.ly/3xZUTtr #VirtualInvestor #chroniccough #neuropathicpain #migraine #hyperactivebladder
-
-
Exxel Pharma to Participate in the Virtual Investor Lunch Break: The Exxel Opportunity. https://bit.ly/4a2rAna #VirtualInvestor #chroniccough #neuropathicpain #migraine #hyperactivebladder
-
Access our in-depth library of scientific publications and presentations here: https://bit.ly/3tSFFVa #chroniccough #neuropathicpain #migraine #hyperactivebladder
-
-
Refractory #chroniccough is a significant unmet need and represents a large market.
-
-
Our breakthrough solution for #chroniccough is a first-in-class, proprietary small molecule leveraging a differentiated approach by inhibiting the FAAH enzyme. Learn more here: https://bit.ly/3Mh2Xu4
-
-
We are leveraging innovative science and research pioneered by our team and other academic labs to reduce #neuronalhypersensitivity and address a number of #chronicconditions, including #chroniccough. https://bit.ly/49cZ3MO
-